Event details
Thank you for your interest in this non-promotional medical education webinar initiated, organised, developed and funded by Madrigal for HCPs only on Wednesday 23rd September 2026 from 19:00–20:00 BST.
This webinar will provide practical insights into the use of non-invasive tests (NITs) and guideline-informed approaches to support earlier identification, risk stratification and referral of patients with suspected metabolic dysfunction-associated steatohepatitis (MASH) within local clinical pathways.
Meeting objectives
- Recognise the progression and risk factors for fibrosis in MASH and impact of metabolic dysfunction
- Incorporating NITs into clinical practice
- Understand the local referral and management pathway in Bristol, North Somerset & South Gloucestershire Integrated Care System (ICS)
![]() |
This webinar has been approved by the Faculty of Pharmaceutical Medicine for 1 CPD point. |
Meeting agenda
19:00−19:05
Welcome and Introductions

19:05−19:10
MASH Background and Unmet Needs

19:10−19:20
International Guidelines for the Management of MASLD/MASH

19:20−19:30
Assessment and Diagnosis of MASH

19:30−19:40
Local Pathways and Considerations

19:45−20:00
Q&A
MASH; Metabolic Dysfunction-Associated Steatohepatitis
MASLD; Metabolic Dysfunction-Associated Steatotic Liver Disease
Discover resources to help strengthen identification, risk stratification and service delivery in MASH care. Scan the QR code or visit Madrigal Connect to explore practical tools and examples.
